GPA (n=243) | MPA (n=45) | EGPA (n=69) | Total (n=357) | |
---|---|---|---|---|
VTE, n (%) | 20 (8.2) | 3 (6.7) | 7 (10.1) | 30 (8.4) |
Men, n | 11 | 2 | 3 | 16 |
Median age, year (range) | 51 (25–78) | 49 (46–64) | 53 (30–65) | 52 (25–78) |
Traditional VTE risk factors* | 5 | 1 | 2 | 8 |
VTE events | 14 | 2 | 5 | 21 |
DVT | 12 | 2 | 5 | 19 |
DVT+PE | 2 | 0 | 0 | 2 |
Other vein thrombosis† | 8 | 1 | 2 | 11 |
Time to VTE after diagnosis | ||||
First 6 months | 5/16 | 3/3 | 2/5 | 10/24 |
First 12 months | 8/16 | 3/3 | 3/5 | 13/24 |
Death from any cause | 2 | 0 | 0 | 2 |
Death from PE | 0 | 0 | 0 | 0 |
*Metabolic syndrome, type 2 diabetes mellitus, multiple intravenous injections, chronic venous insufficiency. †Orbital vein (2), jugular vein (1), renal vein (1), testicular vein (1), superficial veins (6).
DVT, deep vein thrombosis; EGPA, eosinophilic granulomatosis with polyangiitis; GPA, granulomatosis with polyangiitis; MPA, microscopic polyangiitis; PE, pulmonary embolism; VTE, venous thromboembolism.